FDA Clearance Tracker · K233358
SCoV-2 Ag Detect Rapid Test
Last checked: Nov 20, 2026Latest source record: Aug 23, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Aug 23, 2024
Substantially Equivalent
Time to decision
329 days
Received Sep 29, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Dual Track
Device class
Class II
The decision
- FDA number
- K233358
- Device name
- SCoV-2 Ag Detect Rapid Test
- Applicant
- InBios International, Inc.
- Applicant location
- Seattle, WA
- Received
- Sep 29, 2023
- Decided
- Aug 23, 2024
- Decision
- Substantially Equivalent
- Submission type
- Dual Track
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3982
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QVF. The earliest in FDA's data is DEN220039, decided Mar 8, 2023.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K233358
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for InBios International, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251595 · Decided Oct 12, 2025 · 138 days after receipt
Device type: Over-The-Counter Covid-19 Antigen Test (QYT) · Laboratory Medicine & Pathology
- Active Anthrax DetectTM Plus Rapid TestNew device typeDe Novo
DEN220044 · Decided Feb 3, 2023 · 210 days after receipt
Device type: Simple In Vitro Diagnostic Device For The Detection Of Secreted Proteins From Bacillus Spp. In Human Clinical Samples (QUU) · Laboratory Medicine & Pathology
- ZIKV Detect 2.0 IgM Capture ELISANew device typeDe Novo
DEN180069 · Decided May 23, 2019 · 148 days after receipt
Device type: Zika Virus Serological Reagents (QFO) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.